Oocyte vitrification modifies nucleolar remodeling and zygote kinetics-a sibling study

S Chamayou, S Romano, C Alecci, G Storaci, C Ragolia, A Palagiano, A Guglielmino, S Chamayou, S Romano, C Alecci, G Storaci, C Ragolia, A Palagiano, A Guglielmino

Abstract

Purpose: Oocyte vitrification does not affect embryo quality after oocyte warming, making this method effective in the preservation of female fertility. Morphokinetic parameters can be used to predict the competence of an embryo produced from fresh oocytes. Our aim was to study the effect of oocyte vitrification on zygote-embryo kinetics (pl).

Methods: The embryo-kinetics of fresh and sibling vitrified/warmed oocytes were compared to determine the consequences of oocyte preservation on the timing of embryo development. A 44-hours time-lapse analysis, from the time of ICSI (t0), of 179 fertilized fresh oocytes was compared to 168 fertilized sibling vitrified/warmed oocytes.

Results: Oocyte vitrification accelerated pronuclear disappearance, one-cell stage timing and modified nucleoli activity by increasing their number and decreasing their diameter at the zygote stage. In contrast, embryo kinetics during cleavage were similar to those observed for fresh sibling oocytes based on the parameters examined in this study.

Conclusions: At the zygote stage, oocyte vitrification induces changes in pronuclei stability, probably due to pronuclei envelop instability as well as modifications in nucleoli functionality. Therefore, the predictive morphokinetic parameters on embryo competence found from fresh oocytes must be revised when applied on embryos from vitrified/warmed oocytes.

Figures

Fig. 1
Fig. 1
Embryokinetic from fresh oocytes and sibling vitrified/warmed oocytes from time 0 to 44 h
Fig. 2
Fig. 2
Nucleoli organization prior to pronuclei fading in zygote from fresh (a) and sibling vitrified/warmed (b) oocytes

References

    1. Aguilar J, Motato Y, Escribà MJ, Ojeda M, Munoz E, Meseguer M. The human first cell cycle: impact on implantation. Reprod BioMed Online. 2014;28(4):475–84. doi: 10.1016/j.rbmo.2013.11.014.
    1. Azzarello A, Hoest T, Mikkelsen AL. The impact of pronuclei morphology and dynamicity on live birth outcome after time-lapse culture. Hum Reprod. 2012;27(9):2649–57. doi: 10.1093/humrep/des210.
    1. Boldt J. Current results with slow freezing and vitrification of the human oocyte. Reprod BioMed Online. 2011;23:314–22. doi: 10.1016/j.rbmo.2010.11.019.
    1. Borini A, Coticchio G. The efficacy and safety of human oocyte cryopreservation by slow cooling. Semin Reprod Med. 2009;27:443–9. doi: 10.1055/s-0029-1241053.
    1. Campany G, Taylor A, Braude P, Bolton VN. The timing of pronuclear formation, DNA synthesis and cleavage in the human 1-cell embryo. Hum Reprod. 1996;2(5):299–306. doi: 10.1093/molehr/2.5.299.
    1. Campbell A, Gishel S, Bownam N, Duffy S, Sedler M, Thornton S. Retrospective analysis of outcomes after IVF using an aneuploidy risk model derived from time-lapse imaging without PGS. Reprod BioMed Online. 2013;27(2):140–6. doi: 10.1016/j.rbmo.2013.04.013.
    1. Cao YX, Xing Q, Li L, Cong L, Zhang ZG, Wei ZL, et al. Comparison of survival and embryonic development in human oocytes cryopreserved by slow freezing and vitrification. Fertil Steril. 2009;92:1306–11. doi: 10.1016/j.fertnstert.2008.08.069.
    1. Chamayou S, Alecci C, Ragolia C, Storaci G, Maglia E, Russo E, et al. Comparison of in-vitro outcomes from cryopreserved oocytes and sibling fresh oocytes. Reprod BioMed Online. 2006;12(6):730–6. doi: 10.1016/S1472-6483(10)61085-1.
    1. Chamayou S, Bonaventura G, Alecci C, Tibullo D, Di Raimondo F, Guglielmino A, et al. Consequences of metaphase II oocyte cryopreservation on mRNA content. Cryobiology. 2011;62:130–4. doi: 10.1016/j.cryobiol.2011.01.014.
    1. Chamayou S, Patrizio P, Storaci G, Tomaselli V, Alecci C, Ragolia C, Crescenzo C, Guglielmino A. The use of morphokinetic parameters to select all embryos with full capacity to implant. J Assist Reprod Genet. 2013; 703–710.
    1. Chavez SL, Loewke KE, Han J, Moussavi F, Colls P, Munne S, et al. Dynamic blastomere behaviour reflects human embryo ploidy by the four-cell stage. Nat Commun. 2012;3:1251. doi: 10.1038/ncomms2249.
    1. Chen C. Pregnancy after human oocyte cryopreservation. Lancet. 1986;1:884–6. doi: 10.1016/S0140-6736(86)90989-X.
    1. Ciray HN, Campbell A, Agerholm IE, Aguilar J, Chamayou S, Esbert M and Sayed S. Proposed guidelines on the nomenclature and annotation of dynamic human embryo monitoring by time-lapse user group. Hum Reprod. 2014.
    1. Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2011;96(2):277–85. doi: 10.1016/j.fertnstert.2011.06.030.
    1. Corte Costituzionale. Sentenza n.151, Gazzetta ufficiale del 08 maggio. 2009.
    1. Gook DA, Edgar DH. Human oocyte cryopreservation. Hum Reprod Update. 2007;13(6):591–605. doi: 10.1093/humupd/dmm028.
    1. Herrero J, Tejera A, Albert C, Vidal C, de los Santos MJ, Meseguer M. A time to look back: analysis of morphokinetic characteristics of humen embryo development. Fertil Steril. 2013;100(6):1602–9. doi: 10.1016/j.fertnstert.2013.08.033.
    1. Kuwayama M. Highly efficient vitrification for cryopreservation of human oocytes and embryos: the Cryotop method. Theriogenology. 2007;67(1):73–80. doi: 10.1016/j.theriogenology.2006.09.014.
    1. Kuwayama M, Vatja G, Kato O, Leibo SP. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod BioMed Online. 2005;11(3):300–8. doi: 10.1016/S1472-6483(10)60837-1.
    1. Li JJ, Lian HY, Zhang SY, Cui W, Sui HS, Han D, et al. Regulation of fusion of the nucleolar precursor bodies following activation of mouse oocytes: roles of the maturation-promoting factors and mitogen-activated protein kinases. Zygote. 2012;20(3):291–303. doi: 10.1017/S0967199411000219.
    1. Lockwood GM. Social egg freezing: the prospect of reproductive ‘immortality’ or a dangerous delusion? Reprod BioMed Online. 2011;23(3):334–40. doi: 10.1016/j.rbmo.2011.05.010.
    1. Meseguer M, Herrero J, Tejera A, Hilligsoe KM, Ramsing NB, Remohi J. The use of morphokinetics as a predictoor of embryo implantation. Hum Reprod. 2011;26(10):2658–71. doi: 10.1093/humrep/der256.
    1. Nagy ZP, Chang CC, Shapiro DB, Bernal DP, Kort HI, Vatja G. The efficacy and safety of human oocyte vitrification. Semin Reprod Med. 2009;27:450–5. doi: 10.1055/s-0029-1241054.
    1. Parlamento Italiano. Legge n.40: Norme in material di procreazione medicalmente assistita. Gazzetta ufficiale, n.45 del 24 febbraio. 2004.
    1. Porcu E, Fabbri R, Seracchioli RADD. Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes. Fertil Steril. 1997;68:724–6. doi: 10.1016/S0015-0282(97)00268-9.
    1. Rienzi L, Romano S, Albricci L, Maggiulli R, Capalbo A, Baroni E, et al. Embryo development of fresh ‘versus’ vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Reprod BioMed Online. 2010;25(1):66–73.
    1. Scott L, Alvero R, Leondires M, Miller B. The morphology of human pronuclear embryos is positively related to blastocysts development and implantation. Hum Reprod. 2000;15(11):2394–403. doi: 10.1093/humrep/15.11.2394.
    1. The Practice Committees of the American Society for Reproduction Medicine and the Society for Assisted Reproduction Technology Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99(1):37–43. doi: 10.1016/j.fertnstert.2012.09.028.
    1. Wong C, Chen AA, Behr B, Shen S. Time-lapse microscopy and image analysis in basic and clinical embryo development research. Reprod BioMed Online. 2013;26:120–9. doi: 10.1016/j.rbmo.2012.11.003.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner